IP Verse

Tillotts Pharma Ag opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof

Applicant:

Opposition Date:

Feb 28, 2019

Patent Number:

Title:

Mesalazine Tablet Having Improved Dissolution

Applicant:

Opposition Date:

Nov 21, 2018

Patent Number:

Title:

Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance

Applicant:

Opposition Date:

Feb 5, 2018

Patent:

Grant Date:

Nov 23, 2022

Title:

Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension Layering

Oppositions:

Patent Number	Title	Applicant	Opposition Date
EP2461802	Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof	SOFAR SPA	Feb 28, 2019
EP2611429	Mesalazine Tablet Having Improved Dissolution	DISPHAR INTERNATIONAL B.V.	Nov 21, 2018
EP2552955	Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance	CHUGAI SEIYAKU KABUSHIKI KAISHA	Feb 5, 2018

Patent Number	Grant Date	Title	Total Oppositions
EP3459528	Nov 23, 2022	Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension Layering	1

CHUGAI SEIYAKU KABUSHIKI KAISHA

DISPHAR INTERNATIONAL B.V.

HEIROTH, SEBASTIAN, DR.

Feel free to send us a message here and we will get back to you